Details : One of the leading causes of cancer death worldwide. 

Research Status : Show promise : 

Reseach Findings : GcMAF (Gc protein-derived macrophage-activating factor) is a type of immunotherapy that has been explored for its potential benefits in treating Lung cancer. 

How GcMaf could benefit in the treatment of lung cancer :   

1. Activation of macrophages to target and destroy cancer cells.
2. Inhibition of angiogenesis, preventing new blood vessel formation for tumors.
3. Induction of apoptosis, leading to programmed cell death in cancer cells.
4. Enhancement of the overall immune response against cancer cells.
5. Reduction in tumor size.
6. Improvement in oxygen levels due to reduced tumor burden.
7. Alleviation of coughing as the tumor shrinks.
8. Enhanced phagocytosis, allowing macrophages to engulf and digest cancer cells.
9. Anti-inflammatory effects, reducing cancer-associated inflammation.
10. Increased energy levels as the immune system strengthens.
11. Healthy weight gain during recovery.
12. Improved lung function and easier breathing.
13. Effectiveness without the need for traditional chemotherapy.
14. Less invasive treatment compared to surgery and Chemotherapy.
15. Overall improvement in quality of life.
16. Immune System Activation:GcMAF activates macrophages, which are crucial for attacking cancer cells.
17. Reduction of Nagalase Activity: Cancer cells produce Nagalase, an enzyme that inhibits the immune system. GcMAF can reduce Nagalase levels, potentially restoring immune function.
18. Support for Conventional Therapies: GcMAF can enhance the effectiveness of traditional treatments like chemotherapy and radiation.
19. Minimal Side Effects:GcMAF therapy has been reported to have minimal adverse effects and no lasting side effects, compared to conventional cancer treatments. 
20. Potential for Long-Term Remission: Studies suggest that GcMAF can lead to long-term remission in cancer patients.
21. 21. Improved Quality of Life:Patients receiving GcMAF have reported better overall health and fewer cancer-related symptoms.
22. Reduction in Metastasis: GcMAF can help prevent the spread of cancer to other parts of the body.
23. Personalized Treatment: GcMAF therapy can be tailored to individual patients based on their specific immune profiles.